Related references
Note: Only part of the references are listed.Successful clinical and virological outcomes of liver transplantation for HDV/HBV-related disease after long-term discontinuation of hepatitis B immunoglobulins
Ilaria Lenci et al.
CLINICAL TRANSPLANTATION (2023)
Treating hepatitis D with bulevirtide-Real-world experience from 114 patients
Christopher Dietz-Fricke et al.
JHEP REPORTS (2023)
Liver Transplantation in Hepatitis B/Hepatitis D (Delta) Virus Coinfected Recipients
Silvia Martini et al.
TRANSPLANTATION (2022)
2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus-related infection before and after liver transplantation
Christophe Duvoux et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivo
Katja Giersch et al.
GUT (2019)
Recapitulation of HDV infection in a fully permissive hepatoma cell line allows efficient drug evaluation
Florian A. Lempp et al.
NATURE COMMUNICATIONS (2019)
Are immunoglobulins against the HBsAg still needed in liver transplantation for hepatitis D?
Silvia Martini et al.
HEPATOLOGY (2018)
Shorter hepatitis B immunoglobulin administration is not associated to hepatitis B virus recurrence when receiving combined prophylaxis after liver transplantation
Sabela Lens et al.
LIVER INTERNATIONAL (2018)
Oral Nucleoside/Nucleotide Analogs Without Hepatitis B Immune Globulin After Liver Transplantation for Hepatitis B
James Fung et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Liver transplantation for HBV-related cirrhosis in Europe: An ELTR study on evolution and outcomes
Patrizia Burra et al.
JOURNAL OF HEPATOLOGY (2013)
Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation
Ingmar Mederacke et al.
JOURNAL OF HEPATOLOGY (2012)
Virology of Hepatitis D Virus
John M. Taylor
SEMINARS IN LIVER DISEASE (2012)
Entecavir Monotherapy Is Effective in Suppressing Hepatitis B Virus After Liver Transplantation
James Fung et al.
GASTROENTEROLOGY (2011)
Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study
M. Buti et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Occult Hepatitis B Virus Infection of Donor and Recipient Origin After Liver Transplantation Despite Nucleoside Analogue Prophylaxis
Cindy Ka Yee Cheung et al.
LIVER TRANSPLANTATION (2010)
A 28-Year Study of the Course of Hepatitis Δ Infection: A Risk Factor for Cirrhosis and Hepatocellular Carcinoma
Raffaella Romeo et al.
GASTROENTEROLOGY (2009)
Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B
G Fattovich et al.
GUT (2000)